Facebook
Twitter
Telegram
Report an ErrorCleveland BioLabs, Inc. Financial Statements 2011-2024 | CBLI
Annual Financial Statements Cleveland BioLabs, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
56.9 M | 35.6 M | 17.7 M | 35.9 M | 18.6 M | 26.8 M | 10.6 M | 30.6 M | 58.7 M | 102 M |
Shares |
12.4 M | 11.3 M | 11.3 M | 11.2 M | 11 M | 7.06 M | 2.7 M | 2.25 M | 1.87 M | 1.63 M |
Net Income |
-2.4 M | -2.65 M | -3.61 M | -9.71 M | -2.66 M | -12.6 M | 1.63 M | -17.3 M | -18.2 M | -4.01 M |
Revenue |
263 K | 1.11 M | 1.14 M | 1.95 M | 3.52 M | 2.71 M | 3.7 M | 8.49 M | 3.57 M | 8.79 M |
EBITDA |
-2.58 M | -2.35 M | -4.78 M | -5.58 M | -6.29 M | -10.7 M | -14.2 M | -22.6 M | -29.6 M | -24.6 M |
Operating Expenses |
2.85 M | 3.47 M | 5.94 M | 7.55 M | 9.87 M | 13.5 M | 18.1 M | 31.6 M | 33.6 M | 33.9 M |
General and Administrative Expenses |
2.16 M | 1.82 M | 2.32 M | 2.5 M | 3.38 M | 6.36 M | 8.47 M | 12 M | 11.1 M | 11.1 M |
All numbers in USD currency